Acne/Pimple Control NDC 51393-6112

NDC codes

FDA NDC Directory

Product NDC (as listed)51393-6112Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51393-6112Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51393-6112-4	51393611204	4 mL in 1 BOTTLE, DISPENSING (51393-6112-4)Marketed from Jul 1, 2016

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acne/Pimple Control
Generic name (nonproprietary): calendula officinalis flowering top and silicon dioxide
Active ingredients: Calendula officinalis flowering top — 6 [hp_X]/1000mLSilicon dioxide — 6 [hp_X]/1000mL
Dosage form: Solution/ drops
Route: Topical
Labeler: Forces of Nature
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Apr 6, 2011
Listing expires: Dec 31, 2027
Identifiers: Product ID 51393-6112_0983b8ae-d82b-4136-b4e8-7f9c337cf771SPL ID 0983b8ae-d82b-4136-b4e8-7f9c337cf771SPL set ID e871e46e-463e-49ec-a2af-5aa98548ee12UNII 18E7415PXQ, ETJ7Z6XBU4

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451393611204 followed by a unit qualifier and the quantity

Package 51393-6112-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 13, 2026.

Indications (excerpt from the label)

Indications Clears up acne, blemishes, and reduces skin inflammation associated with acne. Reduces the number of acne blemishes and allows skin to heal. Penetrates pores to control acne and keep skin clear of new acne pimples.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)